loading
Ginkgo Bioworks Holdings Inc stock is traded at $12.55, with a volume of 1.73M. It is up +6.72% in the last 24 hours and down -5.99% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$11.76
Open:
$11.8
24h Volume:
1.73M
Relative Volume:
1.18
Market Cap:
$590.97M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-0.9661
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
-4.78%
1M Performance:
-5.99%
6M Performance:
+15.99%
1Y Performance:
+51.20%
1-Day Range:
Value
$11.71
$12.87
1-Week Range:
Value
$10.96
$14.20
52-Week Range:
Value
$5.00
$16.85

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name
Name
Ginkgo Bioworks Holdings Inc
Name
Phone
(877) 442-5362
Name
Address
27 DRYDOCK AVENUE, BOSTON
Name
Employee
834
Name
Twitter
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
DNA
Ginkgo Bioworks Holdings Inc
12.55 816.96M 217.11M -651.19M -387.26M -12.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-24 Downgrade BTIG Research Neutral → Sell
May-10-24 Downgrade William Blair Mkt Perform → Underperform
Nov-14-23 Downgrade Raymond James Outperform → Mkt Perform
Nov-09-23 Downgrade BTIG Research Buy → Neutral
Jun-02-23 Downgrade Goldman Neutral → Sell
May-11-23 Downgrade William Blair Outperform → Mkt Perform
Nov-29-22 Initiated Berenberg Buy
Oct-04-22 Initiated Morgan Stanley Equal-Weight
May-18-22 Downgrade BofA Securities Neutral → Underperform
Mar-02-22 Resumed Cowen Outperform
Feb-23-22 Initiated Goldman Neutral
Feb-01-22 Initiated BofA Securities Neutral
Jan-28-22 Initiated BofA Securities Buy
Jan-07-22 Initiated BTIG Research Buy
Nov-29-21 Initiated Jefferies Buy
Oct-13-21 Initiated Raymond James Outperform
Oct-12-21 Initiated William Blair Outperform
Sep-20-21 Initiated HSBC Securities Buy
View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

pulisher
Aug 20, 2025

Earnings call transcript: Ginkgo Bioworks Q2 2025 sees stock drop amid EPS miss - Investing.com

Aug 20, 2025
pulisher
Aug 20, 2025

Ginkgo's Datapoints Collaborates With Inductive Bio, Tangible Scientific to Make Lab-in-the-Loop Drug Discovery - MarketScreener

Aug 20, 2025
pulisher
Aug 20, 2025

Ginkgo Datapoints, Tangible Scientific, and Indictive Bio Partner to Deploy AI-Driven Lab-In-The-Loop Workflows Across the Biopharma Industry - MarketScreener

Aug 20, 2025
pulisher
Aug 20, 2025

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry - PR Newswire

Aug 20, 2025
pulisher
Aug 19, 2025

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth - ADVFN Brasil

Aug 19, 2025
pulisher
Aug 19, 2025

Ranking Ginkgo Bioworks Holdings Inc. among high performing stocks via tools2025 Price Targets & Smart Money Movement Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will Ginkgo Bioworks Holdings Inc. stock go up soonJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Detecting price anomalies in Ginkgo Bioworks Holdings Inc. with AIJuly 2025 Earnings & Fast Moving Stock Watchlists - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is a relief rally coming for Ginkgo Bioworks Holdings Inc. holdersJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is now a turning point for Ginkgo Bioworks Holdings Inc.Wall Street Watch & Risk Managed Trade Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What to expect from Ginkgo Bioworks Holdings Inc. in the next 30 daysRisk Management & Precise Entry and Exit Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Long term hold vs stop loss in Ginkgo Bioworks Holdings Inc.Quarterly Profit Review & Accurate Buy Signal Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is Ginkgo Bioworks Holdings Inc. stock reversal real or fake2025 Year in Review & Long-Term Capital Growth Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Leading vs lagging indicators on Ginkgo Bioworks Holdings Inc. performanceLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Ginkgo Bioworks Holdings Inc. stock outlook for YEARWeekly Market Outlook & Low Risk High Win Rate Stock Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What’s next for Ginkgo Bioworks Holdings Inc. stock priceRate Cut & High Accuracy Trade Signal Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What makes Ginkgo Bioworks Holdings Inc. stock price move sharplySell Signal & Capital Efficiency Focused Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN

Aug 19, 2025
pulisher
Aug 18, 2025

Quant Tools Rank Ginkgo Bioworks Holdings Inc. as High Risk High RewardMarket Sentiment Report & Capital Efficient Trade Techniques - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 17, 2025

Using data models to predict Ginkgo Bioworks Holdings Inc. stock movement2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Applying Elliott Wave Theory to Ginkgo Bioworks Holdings Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Predicting Ginkgo Bioworks Holdings Inc. trend using moving averagesJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Ginkgo Bioworks Holdings Inc. recovery potential after sell offQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Ginkgo Bioworks Earnings Call: Mixed Sentiment and Strategic Growth - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

Is Ginkgo Bioworks Holdings Inc. stock ready for a breakoutVolume Spike & Pattern Based Trade Signal System - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 17:28:08 - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Is Ginkgo Bioworks Holdings Inc. stock a falling knife or bargain buy2025 Pullback Review & Weekly Momentum Stock Picks - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 14, 2025

How Ginkgo Bioworks Holdings Inc. stock performs during market volatility2025 Trading Recap & Growth Focused Entry Reports - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Ginkgo Bioworks shares rise 1.21% premarket after appointing Brian O'Sullivan as Head of Commercial for Ginkgo Automation. - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial for External Growth - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Ginkgo Bioworks Holdings: Mixed Earnings Call with Strategic Growth Potential - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Ginkgo Bioworks Holdings Reports Q2 2025 Earnings: Revenue Down 12%, Net Loss Narrows by 72% - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Ginkgo Bioworks Holdings Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Ginkgo Automation Appoints Brian O'sullivan as Head of Commercial - MarketScreener

Aug 12, 2025
pulisher
Aug 12, 2025

Ginkgo Bioworks appoints Brian O’Sullivan as head of commercial By Investing.com - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

TR | OpenAI4o Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Raises Target Price to $12 - 富途牛牛

Aug 12, 2025
pulisher
Aug 11, 2025

Is Ginkgo Bioworks (DNA) a Sell Despite Recent Institutional Buying and Earnings Outages? - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Ginkgo Bioworks: Assessing the Recent Rally for Potential Value - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Ginkgo Bioworks: Sell The Recent Rally (NYSE:DNA) - Seeking Alpha

Aug 11, 2025
pulisher
Aug 10, 2025

Comparing Ginkgo Bioworks Holdings Inc. in custom built stock radarsFree Swing Trade Entry With Volume Triggers - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.33 - Yahoo Finance

Aug 10, 2025
pulisher
Aug 09, 2025

William Blair Maintains Sell Rating on Ginkgo Bioworks Holdings - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 09, 2025
pulisher
Aug 08, 2025

Ginkgo achieves $250M cost-reduction goal early, bolsters financial position - The Business Journals

Aug 08, 2025
pulisher
Aug 08, 2025

Ginkgo Bioworks stock price target raised to $16 from $12 at TD Cowen - Investing.com India

Aug 08, 2025
pulisher
Aug 08, 2025

Ginkgo Bioworks shares rise 3.01% premarket after achieving $250 million cost reduction goal. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Ginkgo Bioworks Q2 2025 Earnings: Revenue Surpasses Estimates, Net Loss Narrows to $60M - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $16 at TD Cowen - StreetInsider

Aug 08, 2025
pulisher
Aug 08, 2025

Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... By GuruFocus - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Ginkgo Bioworks Q2 2025 Earnings Call Transcript: Progress Towards Adjusted EBITDA Breakeven and Life Science Tools Expansion - AInvest

Aug 08, 2025

Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Ginkgo Bioworks Holdings Inc Stock (DNA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Coen Steven P.
See remarks
Jul 17 '25
Sale
9.84
1,084
10,669
10,679
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):